What do systematic reviews say?

Adverse events · people with intermediate‐stage hepatocellular carcinoma

Serious adverse events · adult patients with non‐paracetamol (acetaminophen)‐related acute liver failure

Serious adverse events · people with advanced biliary tract carcinomas

Serious adverse events · people with advanced biliary tract carcinomas

Serious adverse events · people with advanced biliary tract carcinomas

Serious adverse events · people with advanced biliary tract carcinomas

Serious adverse events · participants with unresectable hepatocellular carcinoma

Serious adverse events · participants with unresectable hepatocellular carcinoma

Serious adverse events · people with primary sclerosing cholangitis

Serious adverse events · hospitalised adults at nutritional risk

Number of adverse events · people with primary sclerosing cholangitis

Non‐serious adverse events · people with resectable cholangiocarcinoma

Non‐serious adverse events · adults with oesophageal varices

Serious adverse events (number) · participants with alcoholic hepatitis (all severity)

Serious adverse events (number) · participants with alcoholic hepatitis (all severity)

Serious adverse events (number) · participants with alcoholic hepatitis (all severity)

Serious adverse events (number) · participants with severe alcoholic hepatitis

Serious adverse events (number) · participants with severe alcoholic hepatitis

Serious adverse events (number) · alcohol‐related disorders (others)

Serious adverse events (number) · participants with alcoholic hepatitis (all severity)